Local Delivery of Recombinant Adenovirus Expressing Hepatitis B Virus X Protein and Interleukin-12 Results in Antitumor Effects Via Inhibition of Hepatoma Cell Growth and Intervention of Tumor Microenvironment

Hong He,Ping Fan,Tao Yin,Qiaoling Chen,Huashan Shi,Sijia Liu,Haoyu Li,Qiuping Jing,Yingying Yan,Hailong Zhang,Li Yang,Yanjun Wen,Yuhua Li,Ping Cheng
DOI: https://doi.org/10.3892/ijmm.2012.1027
IF: 5.314
2012-01-01
International Journal of Molecular Medicine
Abstract:Hepatocellular carcinoma (HCC) is a typical hypervascular tumor. Our previous studies have demonstrated that hepatitis B virus X protein (HBx) was able to inhibit the growth of HCC cells via inducing apoptosis and inhibiting tumor angiogenesis. Interleukin-12 (IL-12) is a disulfide-linked heterodimeric cytokine with potent immunostimulatory activity and anti-angiogenic properties. In this study, to further investigate the regulatory effect of IL-12 on HBx-mediated intervention of hepatoma microenvironment especially on intervention of neovessels and immune microenvironment, we constructed the recombinant adenovirus expressing HBx and mouse IL-12 named Ad-H Bx-mIL-12. HBx-mIL-12 could effectively suppress tumor growth and induce apoptosis in vivo. Moreover, treatment with Ad-HBx-mIL-12 not only induced a massive accumulation of immune cells (CD8(+)T leukocytes, macrophages and dendritic cells) in tumors in situ, also apparently reduced the number of angiogenic blood vessels within tumor tissues. These results suggest that HBx-mIL-12 can not only induce cell cycle arrest and apoptosis in HCC cells, but also effectively shift the tumor microenvironment from pro-oncogenic to antitumor through recruitment of immune cells and inhibiting stromal cell growth, such as vascular endothelial cells.
What problem does this paper attempt to address?